Thermo Fisher Scientific Inc. partnered with Advanced Electrophoresis Solutions Ltd. to offer high-performing capillary electrophoresis devices for whole-column imaging detection by combining crucial protein separation methods with mass spectrometry (MS). Further, the companies will showcase how well their technologies work together for protein analysis and will benefit the scientists that work in the biopharmaceutical, clinical, food analysis, and academic fields.
QIAGEN introduced a capillary electrophoresis (CE) device, QIAxcel Connect, to provide more convenience, and offer high analytical power in a wide range of applications.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5146
Published Date: Aug 10, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising prevalence of cancer across the globe and the rising demand in biotechnology are the major factors driving the growth of the market.
The market size of Capillary Electrophoresis is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher, Bio-Techne, PerkinElmer Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation.
The academic and research institutions segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.